These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 34459959

  • 21. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1279-83. PubMed ID: 16796890
    [Abstract] [Full Text] [Related]

  • 22. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
    Mahmoudi L, Asadi S, Al-Mousavi Z, Niknam R.
    Clin Nutr; 2021 May 16; 40(5):2999-3005. PubMed ID: 33341312
    [Abstract] [Full Text] [Related]

  • 23. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
    Saneian H, Khalilian L, Heidari-Beni M, Khademian M, Famouri F, Nasri P, Hassanzadeh A, Kelishadi R.
    J Pediatr Endocrinol Metab; 2021 Jul 27; 34(7):897-904. PubMed ID: 33939897
    [Abstract] [Full Text] [Related]

  • 24. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S, Sohrabpour AA, Foroughi F, Alvandi E, Esmaillzadeh A.
    Trials; 2019 Mar 04; 20(1):153. PubMed ID: 30832722
    [Abstract] [Full Text] [Related]

  • 25. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.
    BMC Complement Altern Med; 2019 Mar 12; 19(1):59. PubMed ID: 30871514
    [Abstract] [Full Text] [Related]

  • 26. Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial.
    Soleimani D, Rezaie M, Rajabzadeh F, Gholizadeh Navashenaq J, Abbaspour M, Miryan M, Razmpour F, Ranjbar G, Rezvani R, Jarahi L, Hashemy SI, Goshayeshi L, Nematy M.
    Phytother Res; 2021 Mar 12; 35(3):1669-1679. PubMed ID: 33166032
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ, Yi DY, Yang HR.
    J Korean Med Sci; 2015 Dec 12; 30(12):1821-7. PubMed ID: 26713058
    [Abstract] [Full Text] [Related]

  • 30. The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Shabani-Borujeni M, Modaresi S, Gholamalizadeh M, Doaei S.
    Front Pharmacol; 2021 Dec 12; 12():732496. PubMed ID: 34803681
    [Abstract] [Full Text] [Related]

  • 31. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
    Hu H, Wang J, Li X, Shen L, Shi D, Meng J.
    Curr Pharm Des; 2021 Dec 12; 27(29):3235-3243. PubMed ID: 33719959
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats.
    Yin Y, Liu H, Zheng Z, Lu R, Jiang Z.
    Biomed Pharmacother; 2019 Mar 12; 111():1290-1296. PubMed ID: 30841442
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A, Mohammadi H, Miraghajani M, Ghaedi E.
    Crit Rev Food Sci Nutr; 2019 Mar 12; 59(15):2494-2505. PubMed ID: 29584449
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL, Zhang PH, Yan HH.
    Front Nutr; 2023 Mar 12; 10():1014010. PubMed ID: 36866059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.